US Patent 11384375 Immobilized poly(n)polymerase
Patent 11384375 was granted and assigned to CureVac on July, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 11 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 18 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Benyamin Yazdan Panah0
Markus Conzelmann0
Tilmann Roos0
Veronika Wagner0
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113843750
Date of Patent
July 12, 2022
0Patent Application Number
155701950
Date Filed
May 2, 2016
0Patent Primary Examiner
Edits on 13 Jul, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+355 characters)
US Patent 11384375 Immobilized poly(n)polymerase
Article
The present invention relates to an immobilized poly(N)polymerase (PNP), methods of producing said PNP and uses thereof. Further disclosed is an enzyme reactor and kit comprising the PNP for producing polynucleotidylated ribonucleic acid poly(N)RNA)molecules which are useful in gene therapy, immunotherapy, protein replacement therapy and/or vaccination.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11384375
Date of patent
July 12, 2022
Patent application number
15570195
Date Filed
May 2, 2016
Patent primary examiner
Find more entities like US Patent 11384375 Immobilized poly(n)polymerase
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.